Evogene to Present at Aegis Virtual Conference

Rhea-AI Summary

Evogene Ltd. (NASDAQ-GM: EVGN) will present an overview at the Aegis Capital Corp. Virtual Conference from February 23 to 25, 2022. The presentation is set for February 25 at 9:00 AM EST. Interested participants can access the presentation upon request to Aegis or view the slide deck on Evogene's website. Evogene is a computational biology company aiming to innovate product development in life sciences, using its Computational Predictive Biology platform.

REHOVOT, Israel, Feb. 7, 2022 /PRNewswire/ -- Evogene Ltd. (NASDAQ-GM: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments announced today that it will present a company overview at the Aegis Capital Corp. Virtual Conference to be held on February 25th at 9:00 Eastern. The conference will span three days, starting on February 23rd until February 25th from 8:30AM until 5PM EST.   

Evogene's presentation will be available by request to Aegis from February 23 to 25, 2022. The slide deck will also be made available on Evogene's website at https://www.evogene.com/investor-relations/presentations-and-webcasts/.

To access the event, please download and import the following iCalendar (.ics) files to your calendar system: Aegis Virtual Conference Calendar

About Evogene Ltd.:

Evogene (NASDAQ-GM: EVGN) (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform.  The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ag Ltd. For more information, please visit www.evogene.com.

Contact:

Rivka Neufeld
Investor Relations and Public Relations Manager
E: IR@evogene.com
T: +972-8-931-1940

US Investor Relations:

Joseph Green
Edison Group
E: jgreen@edisongroup.com
T: +1 646-653-7030

Laine Yonker
Edison Group
E: lyonker@edisongroup.com
T: +1 646-653-7035

Logo: https://mma.prnewswire.com/media/890385/Evogene_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/evogene-to-present-at-aegis-virtual-conference-301476348.html

SOURCE Evogene Ltd

FAQ

When is Evogene presenting at the Aegis Virtual Conference?

Evogene will present at the Aegis Capital Corp. Virtual Conference on February 25, 2022, at 9:00 AM EST.

What dates is the Aegis Capital Corp. Virtual Conference held?

The Aegis Capital Corp. Virtual Conference will take place from February 23 to 25, 2022.

Where can I find Evogene's presentation materials?

Evogene's presentation materials will be available on their website from February 23 to 25, 2022.

What is the focus of Evogene's business?

Evogene focuses on revolutionizing product development in life sciences using its Computational Predictive Biology platform.

What is the ticker symbol for Evogene on NASDAQ?

The ticker symbol for Evogene on NASDAQ is EVGN.